AI-generated summary
The authors examined 42 patients with oral lichen planus who responded differently to therapy, measuring acetylated histone H3 at lysine 9 and DNA double-strand break markers in lesions. They report that patients with high H3K9ac levels failed to respond to therapy or relapsed soon after, and that poor responders also had more DNA double-strand breaks. The authors suggest these markers may serve as epigenetic markers for recurrence.
- Participants
- 42
- Who or what was studied
- 42 patients with oral lichen planus showing different responses to therapy
- Limits stated in the abstract
- The abstract does not describe the study design, control group, or statistical analysis, so the associations cannot be assessed for strength or causality.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.